RU2020106386A - LIQUID DOSAGE FORM FOR TREATMENT AND PREVENTION OF INFLUENZA AND ARVI - Google Patents
LIQUID DOSAGE FORM FOR TREATMENT AND PREVENTION OF INFLUENZA AND ARVI Download PDFInfo
- Publication number
- RU2020106386A RU2020106386A RU2020106386A RU2020106386A RU2020106386A RU 2020106386 A RU2020106386 A RU 2020106386A RU 2020106386 A RU2020106386 A RU 2020106386A RU 2020106386 A RU2020106386 A RU 2020106386A RU 2020106386 A RU2020106386 A RU 2020106386A
- Authority
- RU
- Russia
- Prior art keywords
- dosage form
- pharmaceutically acceptable
- form according
- acid
- imidazol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2020106386A RU2770521C2 (en) | 2020-02-11 | 2020-02-11 | Liquid dosage form for treatment and prevention of flu and arvi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2020106386A RU2770521C2 (en) | 2020-02-11 | 2020-02-11 | Liquid dosage form for treatment and prevention of flu and arvi |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018137368A Division RU2737086C2 (en) | 2018-10-23 | 2018-10-23 | Liquid dosage form for treating and preventing influenza and arvi |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2020106386A3 RU2020106386A3 (en) | 2021-08-11 |
RU2020106386A true RU2020106386A (en) | 2021-08-11 |
RU2770521C2 RU2770521C2 (en) | 2022-04-18 |
Family
ID=77336030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2020106386A RU2770521C2 (en) | 2020-02-11 | 2020-02-11 | Liquid dosage form for treatment and prevention of flu and arvi |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2770521C2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9504673B2 (en) * | 2009-05-21 | 2016-11-29 | LTD “Valenta-Intellekt” | Agent for the prophylaxis and treatment of highly pathogenic infectious diseases |
UA115431C2 (en) * | 2011-10-11 | 2017-11-10 | Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" | Use of glutaryl histamine to treat respiratory tract infections |
RU2518314C2 (en) * | 2012-08-30 | 2014-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Method and agent activating irf-3 for treating and preventing diseases caused by (+) rna containing viruses |
RU2546002C1 (en) * | 2014-01-20 | 2015-04-10 | Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" | Pharmaceutical composition in form of tablet and method of obtaining thereof |
RU2610275C2 (en) * | 2015-07-30 | 2017-02-08 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Glutarimide derivative, use thereof, pharmaceutical composition based thereon, synthesis method thereof |
-
2020
- 2020-02-11 RU RU2020106386A patent/RU2770521C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2020106386A3 (en) | 2021-08-11 |
RU2770521C2 (en) | 2022-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100212942B1 (en) | Aqueous risperidone formulation | |
US5854270A (en) | Oral compositions containing ondansetron | |
US20130109729A1 (en) | Pharmaceutical composition | |
NZ208127A (en) | Pharmaceutical compositions containing ranitidine | |
US20090048344A1 (en) | Pharmaceutical composition comprising 5-methyl-2-2' (chloro-6'-fluoroanilino phe nylacetic acid | |
KR20110065417A (en) | Oral pharmaceutical suspension comprising paracetamol and ibuprofen | |
US9801876B2 (en) | Complex granule formulation having improved stability comprising levocetirizine and montelukast | |
US11576878B2 (en) | Oral solutions comprising lisdexamfetamine salts | |
RU2018137368A (en) | LIQUID MEDICINAL FOR TREATMENT AND PREVENTION OF INFLUENZA AND ARVI | |
EP3530289B1 (en) | Oral pharmaceutical solutions comprising melatonin | |
KR20060103336A (en) | Pregabalin composition | |
RU2020106386A (en) | LIQUID DOSAGE FORM FOR TREATMENT AND PREVENTION OF INFLUENZA AND ARVI | |
RU2020106385A (en) | LIQUID DOSAGE FORM FOR TREATMENT AND PREVENTION OF INFLUENZA AND ARVI | |
US7691880B2 (en) | Methylphenidate solution and associated methods of administration and production | |
SK284847B6 (en) | Peroral aqueous solution comprising as active ingredient 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4- piperidinyl]-7-benzofuran-carboxamide and method for its preparation | |
CA2543865A1 (en) | Compositions comprising cyclohexylamines and aminoadamantanes | |
ES2637521T3 (en) | Aripiprazole Formulations | |
NO332096B1 (en) | Oral solution containing galantamine and a soot substance | |
EP0700283B1 (en) | Liquid antacid compositions | |
US20060100271A1 (en) | Stabilized aqueous ranitidine compositions | |
KR20150127483A (en) | Liquid formulation with enhanced stability comprising montelukast or pharmaceutically acceptable salt thereof and method for preparing same | |
AU2008321159B2 (en) | Liquid compositions comprising valsartan | |
ES2311812T3 (en) | USE OF CYCLICAL ACETALS / CETALS TO IMPROVE THE PENETRATION OF ACTIVE PRINCIPLES IN CELLS AND ORGANS. | |
WO2024023367A1 (en) | Lisdexamfetamine containing oral solution | |
US20190336478A1 (en) | Stable oral liquid compositions of enalapril |